Model Medicines Announces AI-driven Drug Discovery Partnership

The collaboration will leverage Model Medicines’ cheminformatic approach to drug discovery to identify drugs for novel antiviral targets uncovered by Sanford Burnham Prebys Medical Discovery Institute.

Model Medicines, an AI drug discovery software company, today announced they have entered into a multi-target collaboration agreement with Sanford Burnham Prebys Medical Discovery Institute to identify and develop drugs for novel antiviral targets.

Leave a Reply

Your email address will not be published. Required fields are marked *